SCHEMBL4138006

SCHEMBL4138006

O=C1C(=Cc2ccccc2Br)SC(=S)N1Cc1ccc2c(c1)OCO2

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 2/20 0.65
▸ KMT2A Q03164 9/20 0.53
▸ MEN1 O00255 8/20 0.53
▸ POLB P06746 4/20 0.53
▸ SMN1; SMN2 Q16637 2/20 0.52
▸ PKM P14618 1/20 0.52
▸ TSHR P16473 1/20 0.52
▸ HSP90AA1 P07900 2/20 0.49
▸ NSD2 O96028 1/20 0.49
▸ APOBEC3G Q9HC16 1/20 0.49
▸ CMA1 P23946 1/20 0.48
▸ CTRC Q99895 1/20 0.46
▸ ALDH1A1 P00352 3/20 0.46
▸ LMNA P02545 3/20 0.46
▸ MAPT P10636 3/20 0.46
▸ TDP1 Q9NUW8 2/20 0.46
▸ HPGD P15428 1/20 0.46
▸ RAB9A P51151 1/20 0.46
▸ ALOX12 P18054 2/20 0.46
▸ RECQL P46063 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4138004 1.00 MAPK1 (0.65) MAPK1KMT2AMEN1POLBSMN1; SMN2
SCHEMBL4014803 0.88 MAPK1 (0.65) MAPK1KMT2AMEN1POLBSMN1; SMN2
SCHEMBL4016078 0.88 MAPK1 (0.65) MAPK1KMT2AMEN1POLBSMN1; SMN2
SCHEMBL4016080 0.88 MAPK1 (0.65) MAPK1KMT2AMEN1POLBSMN1; SMN2
SCHEMBL4148315 0.85 MAPK1 (0.65) MAPK1KMT2AMEN1POLBSMN1; SMN2
SCHEMBL4133327 0.85 MAPK1 (0.62) MAPK1KMT2AMEN1POLBSMN1; SMN2
SCHEMBL4137625 0.85 MAPK1 (0.62) MAPK1KMT2AMEN1POLBSMN1; SMN2
SCHEMBL4133333 0.85 MAPK1 (0.62) MAPK1KMT2AMEN1POLBSMN1; SMN2
SCHEMBL4148317 0.85 MAPK1 (0.65) MAPK1KMT2AMEN1POLBSMN1; SMN2
SCHEMBL4133330 0.85 MAPK1 (0.62) MAPK1KMT2AMEN1POLBSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090247516-A1 3- (BENZO [D] [1,3] DIOXOL-5-YLMETHYL) -4- (THIO) OXO-2- (THIO) OXO-AZOLIDIN-5-YLIDENE DERIVATIVES AS ANTIBACTERIAL AGENTS KOTNIK MIHA 2009-10-01 — — US disclosed
US-20090247516-A1 3- (BENZO [D] [1,3] DIOXOL-5-YLMETHYL) -4- (THIO) OXO-2- (THIO) OXO-AZOLIDIN-5-YLIDENE DERIVATIVES AS ANTIBACTERIAL AGENTS KOTNIK MIHA 2009-10-01 — — US disclosed
EP-1916249-A1 3-(benzo[d][1,3]dioxol-5-ylmethyl)-4-(thio)oxo-2-(thio)oxo-azolidin-5-ylidene derivatives as antibacterial agents LEK Pharmaceuticals D.D. (SI) 2008-04-30 — — EP disclosed
EP-1916249-A1 3-(benzo[d][1,3]dioxol-5-ylmethyl)-4-(thio)oxo-2-(thio)oxo-azolidin-5-ylidene derivatives as antibacterial agents LEK Pharmaceuticals D.D. (SI) 2008-04-30 — — EP disclosed
WO-2008043733-A1 3- (BENZO [D] [1,3] DIOXOL-5-YLMETHYL) -4- (THIO) OXO-2- (THIO) OXO-AZOLIDIN-5-YLIDENE DERIVATIVES AS ANTIBACTERIAL AGENTS LEK PHARMACEUTICAL D.D. (SI) 2008-04-17 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090247516-A1 3- (BENZO [D] [1,3] DIOXOL-5-YLMETHYL) -4- (THIO) OXO-2- (THIO) OXO-AZOLIDIN-5-YLIDENE DERIVATIVES AS ANTIBACTERIAL AGENTS XDH, TXLNA, Q6ZSR9 MAPK1 3035/4885KMT2A 1459/4885MEN1 2336/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback